Loading...
Keywords
Last Name
Institution

Stephanie R Duehlmeyer, PharmD, BCPPS

TitleClinical Pharmacy Specialist
InstitutionChildren's Mercy Kansas City
DepartmentAmbulatory Pharmacy
Address2401 Gillham Rd
Kansas City MO 64108
vCardDownload vCard
    Other Positions
    TitleClinical Assistant Professor
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPharmacy


    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Duehlmeyer S, Meier E, Oermann C. Successful treatment of Stenotrophomonas maltophilia with ceftazidime-avibactam and aztreonam in an individual with cystic fibrosis: A case report. Pediatr Pulmonol. 2025 Jan; 60(1):e27363. PMID: 39451040.
      View in: PubMed
    2. McKinzie CJ, Duehlmeyer SR, Kam CW, Safirstein J. Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy. Pediatr Pulmonol. 2024 Dec; 59(12):3734-3735. PMID: 39210831.
      View in: PubMed
    3. Tam-Williams J, Oermann C, Duehlmeyer S. Adapting to change: A description of prescribing practices of asthma controller medications at a pediatric institution. Pediatr Pulmonol. 2024 Dec; 59(12):3774-3776. PMID: 39150097.
      View in: PubMed
    4. Duehlmeyer S, Elson EC, Oermann CM. Effect of Elexacaftor/Tezacaftor/Ivacaftor on Pseudomonas aeruginosa Acquisition and Chronic Infection at a Single Pediatric Cystic Fibrosis Care Center. J Pediatr Pharmacol Ther. 2024 Apr; 29(2):135-139. PMID: 38596420.
      View in: PubMed
    5. Duehlmeyer SR, Elson EC, Oermann CM. New Tic Disorder in a Child With Cystic Fibrosis Treated With Elexacaftor/Tezacaftor/Ivacaftor. J Pediatr Pharmacol Ther. 2024; 29(1):82-84. PMID: 38332957.
      View in: PubMed
    6. Stephenson KG, Lingle AJ, Baumberger KA, Dellon EP, Esther CR, Meier EM, Oermann CM, Shenoy VK, Smith NR, Wimmer NS, Duehlmeyer SR, Kam CW, McKinzie CJ, Poisson MO, Elson EC. Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis. J Cyst Fibros. 2023 11; 22(6):996-1001. PMID: 37758535.
      View in: PubMed
    7. Elson EC, Capel P, Haynes J, Duehlmeyer S, Fischer M, Escobar H. CFTR Modulator Therapy in an Individual With Cystic Fibrosis Caused by a N1303K CFTR Variant and Infected With Mycobacterium abscessus. J Pediatr Pharmacol Ther. 2022; 27(4):396-399. PMID: 35558347.
      View in: PubMed
    8. Duehlmeyer S, Klockau C, Yu D, Rouch J. Characterization of Therapeutic Drug Monitoring Practices of Voriconazole and Posaconazole at a Pediatric Hospital. J Pediatr Pharmacol Ther. 2021; 26(1):26-32. PMID: 33424497.
      View in: PubMed
    9. Louiselle K, Elson EC, Oschman A, Duehlmeyer S. Impact of COVID-19 pandemic on pharmacy learners and preceptors. Am J Health Syst Pharm. 2020 07 07; 77(14):1097-1099. PMID: 32435815.
      View in: PubMed
    10. Elson EC, Oermann C, Duehlmeyer S, Bledsoe S. Use of telemedicine to provide clinical pharmacy services during the SARS-CoV-2 pandemic. Am J Health Syst Pharm. 2020 06 23; 77(13):1005-1006. PMID: 32369111.
      View in: PubMed
    11. Rotolo SM, Duehlmeyer S, Slack SM, Jacobs HR, Heckman B. Testicular pain following initiation of elexacaftor/tezacaftor/ivacaftor in males with cystic fibrosis. J Cyst Fibros. 2020 09; 19(5):e39-e41. PMID: 32471772.
      View in: PubMed
    Duehlmeyer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (32) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (60) people
    _